Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Russia has proved resilient to western sanctions, says Oleg Deripaska
    • Covid antiviral drug linked to ‘transmissible’ mutations, research finds
    • Global trade falls at fastest pace since pandemic
    • How TSMC’s chip plant is shaking up Japan
    • Greek leftists elect former Goldman Sachs associate as leader
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • ‘Get off the train’: Citi’s Jane Fraser sends tough message on big overhaul
      • Meta pays £149mn to break London office lease
      • Big Four accountancy firms shed UK staff after pandemic hiring boom
      • Santander ditched EY as financial crime consultant over alleged failings
      • Senior Nomura banker barred from leaving mainland China
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • The debt-fuelled bet on US Treasuries that’s scaring regulators
      • US Treasuries sell off as investors fret over long period of high rates
      • Live news: Hunter Biden sues Rudy Giuliani for alleged computer fraud
      • News updates from September 25: Nissan boss says ‘move on’ from petrol cars, Global trade contracts
      • Glencore traded thousands of tonnes of Russian copper through Turkey
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • US Republicans could finally win the argument on immigration
      • What the world should expect from a second Trump term
      • The problem with power parents
      • How the US is crushing Europe’s domestic exchanges
      • Why has Leeds, birthplace of the tram, ground to a halt?
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • Paternity leave in finance: ‘The more men do it, the less of a big deal it becomes’
      • The activist sued by Elon Musk: ‘We have to show we will not be cowed’
      • Success is more complicated than one exceptional individual
      • What Burberry taught me about the marketed mind
      • Can I start a business when I have MS?
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • The generation divide in British chess 
      • Game, set, matched – when David Shrigley met Andy Murray
      • Raffles London and the new era of super-luxe hospitality
      • The best museum gift shops in the world
      • This Is New York review — exhibition captures the city’s unique joy, terror and exhilaration
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Coronavirus treatment

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Tuesday, 26 September, 2023
      Covid-19 vaccines
      EU in talks with Moderna over new vaccine supply deal

      Brussels launches talks for mRNA jabs to augment existing contract with BioNTech/Pfizer

      2 hours ago
      A pharmacist administers a Covid jab made by Moderna
    • Monday, 25 September, 2023
      Covid antiviral drug linked to ‘transmissible’ mutations, research finds

      Big-selling molnupiravir treatment produces permanent mutations that can be passed from patient to patient

      An experimental COVID-19 treatment pill, called molnupiravir
    • Thursday, 14 September, 2023
      Special Report
      FT Health: Communicable Diseases

      Climate change helps the spread of infectious diseases. Plus: rise in fungal infections highlights risks of antimicrobial resistance; Sydney shows how to almost eliminate HIV transmission; wait goes on for effective Long Covid treatments

      a tiger mosquito on a person’s skin
    • Wednesday, 13 September, 2023
      Anjana Ahuja
      The rush to outpace Covid variants

      At least three descendants of Omicron have scientists on alert and vaccination programmes speeding up

      Andy Carter illustration of a man running away from coronavirus proteins while pushing a shopping trolley with a vaccine syringe in it
    • Monday, 11 September, 2023
      Covid-19 vaccines
      FDA approves new Covid-19 boosters from Pfizer and Moderna

      Drug regulator’s decision is the first step towards a new round of jabs as cases rise in the US

      A nurse fills a syringe with Covid-19 vaccine
    • Wednesday, 6 September, 2023
      Covid-19 vaccines
      Latest vaccines help tackle highly mutated new Covid variant

      Preliminary studies find exposure to prevalent XBB.1.5 strain elicits antibodies to BA.2.86

      A medical worker holds a syringe of the Moderna vaccine
    • Wednesday, 30 August, 2023
      Covid-19 vaccines
      England brings forward Covid booster vaccinations to counter new sub-variant

      Potential mutations prompts authorities to begin immunisation rollout in September

      A woman receives an injection
    • Wednesday, 30 August, 2023
      ExplainerCoronavirus
      ‘We haven’t seen the end of Covid’: surge in cases to test health systems

      As vaccines are tweaked while new sub-variants emerge, the virus cannot be treated yet as a seasonal bug

      Health workers wear face masks as they walk out of a government hospital in Chennai, India
    • Thursday, 17 August, 2023
      Covid-19 vaccines
      Jonathan Van-Tam takes role at vaccine maker Moderna

      Prominent figure in UK pandemic response becomes medical consultant at pharma group

      Sir Jonathan Van-Tam
    • Sunday, 6 August, 2023
      News in-depthResearch and development
      UK better prepared for next pandemic, say top scientists

      New vaccines centre supports aim to develop jab for any new potential killer pathogen within 100 days

      Scientists at the Vaccine Development and Evaluation Centre at Porton Down
    • Friday, 21 July, 2023
      UK labour disputes
      Unions call off London Underground strikes after ‘intense’ talks

      Move by RMT, Unite and Aslef comes as stoppage by top NHS doctors in England ends without resolution

      Commuters at Bank station
    • Thursday, 20 July, 2023
      FT Magazine
      How a squad of MAGA warriors flush with cash turned on each other

      A doctor, a model and a boxer raised millions from Covid sceptics and anti-vaxxers. Then a knock-down, drag-out brawl broke out

    • Saturday, 1 July, 2023
      John Gapper
      Three warnings about the obesity pills coming after Wegovy

      New treatments have had remarkable results but there are reasons to be cautious

      An advertisement for Wegovy weight loss injections in the New York subway
    • Wednesday, 14 June, 2023
      FT MagazineGillian Tett
      The perils of open-source AI

      Experts are waking up to the threat posed by artificial intelligence programmes if they fall into malevolent hands

    • Sunday, 11 June, 2023
      BioNTech
      BioNTech faces hundreds of German compensation claims for Covid-19 jab

      Pharmaceuticals producer in first court hearing on Monday

      A patient receives the Pfizer/BioNTech vaccine in Leipzig, Germany
    • Sunday, 4 June, 2023
      Supply chains
      US cancer drug shortage forces doctors to ration life-saving treatments

      Healthcare groups call for reforms to pharma supply chains as up to half a million patients could be affected

    • Friday, 26 May, 2023
      Covid-19 vaccines
      Brussels and Pfizer agree deal to cut supply of Covid vaccines

      Revised contract addresses concerns over costly glut of unwanted shots as public health threat wanes

      Woman receives Covid vaccination jab
    • Sunday, 14 May, 2023
      Novavax Inc
      Cash-strapped Novavax urges governments to honour Covid jab deals

      US biotech group is among coronavirus vaccine makers struggling with reduced demand post-pandemic

      Workers in a Novavax lab in Gaithersburg, Maryland
    • Friday, 12 May, 2023
      Simon Schama
      The thwarting of science will always be a human failing

      From India to Britain, we have always managed to get in the way of our own inventiveness

      Illustration of a hand being held up to say no to vaccines, and breaking an inoculation syringe in half
    • Tuesday, 9 May, 2023
      Janan Ganesh
      The west’s handling of the pandemic beat its own expectations

      A demonised elite produced vaccines and furloughs while a supposedly rebellious public mostly followed the rules

      An elderly couple wearing face masks sit on a bench in Seville in May 2020, as Spain prepares to ease its tough lockdown measures
    • Monday, 1 May, 2023
      Noubar Afeyan
      Moderna co-founder calls on US politicians and judges to stop questioning science

      Noubar Afeyan says court rulings on abortion pills and access to healthcare undermine efforts to combat diseases

      Noubar Afeyan
    • Sunday, 30 April, 2023
      Covid-19 vaccines
      BioNTech/Pfizer’s mooted EU deal for 70mn Covid shots threatens rivals

      European health officials have advocated portfolio diversity to help fight different variants

      A teenager receives a Pfizer COVID-19 vaccine at a vaccination centre
    • Friday, 28 April, 2023
      Special ReportThe Americas’ Fastest Growing Companies
      Moderna tries to show it’s not a ‘one trick pony’

      Covid vaccine maker is sitting on $18bn and embarking on a host of ambitious projects

      A health worker prepares a dose of the Moderna COVID-19 vaccine
    • Wednesday, 26 April, 2023
      Pharmaceuticals sector
      EU aims to create ‘single market for medicines’ with overhaul of pharma rules

      Revamp that would cut drugmakers’ years of market exclusivity meets fierce opposition from sector

      Pharmacy worker opens a drawer full of drugs
    • Monday, 24 April, 2023
      EU business regulation
      EU outlines plan to take control of medicine production in health crises

      Proposal for compulsory licensing risks ire of pharma groups keen to protect patents and revenue

      A lab technician wearing a full body protection suit handles a bottle containing growth media for virus production
    Previous page You are on page 1 Next page

    Recommended

    Covid-19 vaccines
    Covid-19 vaccine tracker: Lowest-income countries lag further behind rest of the world
    Covid-19 vaccines
    Covid vaccine development: The shots available and the doses administered
    Covid-19 vaccines
    In graphics: the UK vaccine supply chain
    Coronavirus: free to read
    Coronavirus tracker: the latest figures as countries fight the Covid-19 resurgence
    Coronavirus tracker

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsProfessional SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on XFT ChannelsFT Schools

    Tools

    PortfolioToday’s Newspaper (FT Digital Edition)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Visual and data journalism
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today’s Newspaper (FT Digital Edition)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In